₹522.55
▼ -3.58 -0.68%
10 Sept 2026
NSE Listed
Sai Parenteral's Limited (SAIPARENT)
Volume: 61,345Avg Vol 1W: 67,573Avg Vol 1M: 1,10,634.652W Range:₹400₹706
Key Ratios
Checked 3h agoMarket Cap₹2,309 Cr
Current Price₹522.55
Previous Close₹526.13
High / Low (52w)₹706 / ₹400
Volume61,345
Avg Vol (1W)67,573
Avg Vol (1M)1,10,634.6
Stock P/E111.18
Book Value₹111.09
Dividend Yield0%
ROE290.5%
ROA145.8%
Revenue (TTM)₹390 Cr
Revenue Growth435.1%
Profit Margin394.7%
Total Debt₹243 Cr
Shares Outstanding4 Cr
Face Value₹5
EPS (TTM)₹4.7
P/B4.7
Debt / Equity0.96
50 DMA₹548.14
200 DMA₹532.3
Day change-0.68%
Price Chart
₹522.55▲ 28.80% · 1Y
2026-04-022026-09-10
20-day avg volume: 1.1L shares
Pros
- Healthy return on equity of 290.5%.
- Company is almost debt-free.
Cons
- Revenue fell 37% YoY.
- Stock trades at a high P/E of 111.
Quarterly Results
| Metric | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|
| Revenue | ₹33 Cr | ₹269 Cr | ₹96 Cr | ₹198 Cr | ₹179 Cr |
| EBITDA | ₹4 Cr | ₹14 Cr | ₹-6 Cr | ₹21 Cr | ₹19 Cr |
| Net Profit | ₹1 Cr | ₹-1 Cr | ₹-7 Cr | ₹13 Cr | ₹8 Cr |
| EPS | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹97 Cr | ₹155 Cr | ₹164 Cr | ₹19 Cr | ₹38 Cr | ₹390 Cr | ₹57 Cr | ₹53 Cr |
| EBITDA | ₹12 Cr | ₹24 Cr | ₹32 Cr | ₹3 Cr | ₹3 Cr | ₹30 Cr | ₹12 Cr | ₹15 Cr |
| Net Profit | ₹4 Cr | ₹8 Cr | ₹14 Cr | ₹1 Cr | ₹0 Cr | ₹14 Cr | ₹10 Cr | ₹9 Cr |
| EPS | 6.16 | 10.54 | 5.43 | — | — | 4.36 | — | — |
Balance Sheet
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Total Assets | ₹134 Cr | ₹268 Cr | ₹272 Cr | ₹1,424 Cr |
| Total Liabilities | ₹102 Cr | ₹192 Cr | ₹177 Cr | ₹929 Cr |
| Equity | ₹31 Cr | ₹76 Cr | ₹96 Cr | ₹495 Cr |
| Total Debt | — | — | — | — |
Cash Flow
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Operating | ₹-10 Cr | ₹-30 Cr | ₹34 Cr | ₹98 Cr |
| Investing | ₹-19 Cr | ₹-46 Cr | ₹0 Cr | ₹-274 Cr |
| Financing | ₹24 Cr | ₹79 Cr | ₹-36 Cr | ₹596 Cr |
| Free Cash Flow | ₹-10 Cr | ₹-30 Cr | ₹34 Cr | ₹98 Cr |
Shareholding
Promoter 51.16% Institutions 12.56% Public 36.29%
About Sai Parenteral's Limited
Healthcare · Drug Manufacturers - General
Sai Parenteral's Limited, a pharmaceutical formulations company, engages in the branded generic formulations and contract development and manufacturing businesses in India and internationally. Its portfolio includes formulation products across various therapeutic areas, such as cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements, analgesics, oncology, and dermatology in various dosage forms, including injectables, solid orals, liquid orals, and topicals. The company was founded in 1988 and is based in Hyderabad, India.
www.saiparenterals.com ↗Efficiency & Working Capital
ROCE2.8%
Interest Coverage1.6
Dividend Payout—
Debtor Days173 d
Inventory Days165 d
Payable Days142 d
Cash Conversion Cycle196 d
Working Capital Days338 d
Shareholding Details
As of 2026-06-30
Promoter51.2%
FII4%
DII8.5%
Institutions12.6%
Public36.3%
Promoter Pledge0%
No. of Shareholders9,312
Shareholding Pattern
Quarterly — figures in %. Latest 7 quarters.
| Period | Mar 2026 | Jun 2026 | Sept 2025 | Mar 2026 | Apr 2026 | Apr 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Promoters | 70.7% | 70.7% | 61.2% | 51.2% | 51.2% | 51.2% | 51.2% |
| FIIs | — | — | 0% | 5.7% | 5.7% | 5.7% | 4% |
| DIIs | — | — | 0% | 12.9% | 12.9% | 12.9% | 8.5% |
| Public | 20.9% | 20.7% | 38.8% | 30.3% | 30.3% | 30.3% | 36.3% |
| Promoter Pledge | — | — | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | — | — | 119 | 7,687 | 7,687 | 7,687 | 9,312 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Vijitha Gorrepati | Shareholding of Promoter and Promoter Group | 28.9% | 1.28 Cr |
| Anil Kumar Karusala | Shareholding of Promoter and Promoter Group | 10.3% | 45,58,597 |
| Aruna Karusala | Shareholding of Promoter and Promoter Group | 7.4% | 32,68,010 |
| Bhaskara Rao Bollineni | Public Shareholding | 4.6% | 20,13,488 |
| Kunal Kakumanu | Shareholding of Promoter and Promoter Group | 4.5% | 20,00,000 |
| Samarsh Capital-samarsh Capital-fund I | Public Shareholding | 3.5% | 15,23,437 |
| Kotak Mahindra Life Insurance Company Ltd. | Public Shareholding | 2.4% | 10,40,328 |
| Aig Direct Llc | Public Shareholding | 2.1% | 9,37,500 |
| Agilis Partners Llp | Public Shareholding | 2.1% | 9,08,027 |
| Kotak Life Sciences Fund I | Public Shareholding | 1.7% | 7,65,282 |
| Nanda Govind Bhattad | Public Shareholding | 1.7% | 7,35,000 |
| Reina R Jaisinghani | Public Shareholding | 1.6% | 7,01,923 |
| Sapna Sameer Shah | Public Shareholding | 1.5% | 6,75,000 |
| Arihant Capital Markets Limited | Public Shareholding | 1.4% | 6,15,926 |
| Pooja Lakshmi Doppalapudi | Public Shareholding | 1.3% | 5,88,700 |
| India Emerging Giants Fund Limited | Public Shareholding | 1.3% | 5,89,466 |
| Morgan Stanley Asia (singapore) Pte. - Odi | Public Shareholding | 1.2% | 5,14,798 |
| Kamala Kakumanu | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Karusala Sashank Mouli | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Mahalakshmi Karusala | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Tanivi Karusala | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Bhavani Davuluri | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Haritha Gorrepati | Shareholding of Promoter and Promoter Group | 0% | 0 |
| V Lakshmiswari | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sp Analytics Private Limited | Shareholding of Promoter and Promoter Group | 0% | 0 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| ANIL KUMAR KARUSALA | Chairman / Executive Director / Managing Director | 2025 |
| Vijitha Gorrepati | E D & Wholetime Director | 2025 |
| G S R Anjaneyulu | Independent Non Exe. Director | 2025 |
| Bhagyashri Dharmasa Zad | Independent Non Exe. Director | 2025 |
| Kalidindi V Raju | Independent Non Exe. Director | 2025 |
| Shivali Aggarwal | Company Sec. & Compli. Officer | 2025 |
| Kunal Kakumanu ( | Additional Director & E D | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹5 | 25 | 22 | 22 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-08-11 | Board Meetings | — |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 15 | 0 | 15 |
| 2025 | 0 | 0 | 0 | 13 | 0 | 13 |
| 2025 | 0 | 0 | 0 | 2 | 0 | 2 |
Company Information
🌐 www.saiparenterals.com ↗
📍 No.39 5th Flr Lavanya Arcade-, Jayabheri Enclave Gachibowli, Ranga Reddy, Telangana, 500032
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search